Cognizant Technology Solutions Corp. (CTSH)

Cognizant's stock has held above its 50-day and 200-day moving averages ($62.48 and $58.18), and analysts are mostly sitting on the sidelines. The shares closed at $64.43, down 0.88% in the latest session, and sit 3.12% above the 50-day SMA of $62.48 and 10.75% above the 200-day SMA of $58.18. The stock is 25.97% below its 52-week high of $87.03 and 73.76% above its 52-week low of $37.08. The question for investors is whether the October 29, 2026 quarterly beat and the trend can carry the shares toward the high while revenue growth lags the sector.

Cognizant reported adjusted EPS of $1.49 on October 29, 2026, against an analyst estimate of $1.46, a beat of 2.05%. The shares rose 4.14% in the first session after the report. The company has beaten the EPS estimate in five of the last six reports, but the reaction has not followed a simple pattern. In the July 29, 2026 report, EPS of $1.37 missed the $1.38 estimate by 0.72%, and the shares fell 3.70% the next session. Earlier beats in April 2026 and July 2025 were also followed by declines, so the price reaction has been mixed across the record.

At a trailing P/E of 11.76, the stock trades at a discount to peers, 66.5% below the sector median P/E of 35.1. Its price-to-sales ratio of 1.31 compares with a sector median of 7.6. Trailing GAAP EPS of $5.48 and a return on equity of 17.37%, above the sector median of 13.4%, support the profitability case.

Of 29 analysts, 13 rate the stock buy or strong buy, 16 rate it hold, and none rate it sell. Three months ago the split was the same 13 buy ratings out of 29. Recent actions on October 26, 2026 by JP Morgan and Wells Fargo kept Overweight ratings, Guggenheim kept Buy on October 27, 2026, and Morgan Stanley and RBC Capital kept their Equal-Weight and Sector Perform ratings on October 27 and October 30. Over the last 18 months, insiders sold $8.0M of stock across 37 sales and bought $210K in one open-market purchase. Insider sales are often planned in advance or made to cover tax on vesting shares, so the purchase carries more signal than the sales.

Our base case is that the stock keeps trading in the range set by its moving averages while the business delivers modest growth. Analysts expect earnings per share to rise 9.3% this fiscal year to $5.77 and another 8.8% next year to $6.28, and expect revenue to grow 4.7% to $22.1B this year. The median 12-month analyst target is $70.00, 8.6% above the price, with a range from $47.00 to $84.00. For the shares to move toward that median, revenue growth would need to pick up from the 4.60% reported for the latest quarter, which trails the sector median of 24.2%. A further quarterly miss, or a close below the 50-day SMA at $62.48, would weaken the trend case. A sustained move above the 20-day EMA and then the 52-week high of $87.03 would strengthen it. Consensus stays at Hold with 16 of 29 analysts at hold and no sell ratings, so a shift in ratings would matter more than a single session.

Support sits at $62.48, the 50-day simple moving average, which is the nearest level below the price and the one the stock would meet first on a fall. Below it is the 200-day simple moving average at $58.18, which the price has stayed above on the trend reading. The third support is the 52-week low of $37.08. Resistance starts with the 20-day exponential moving average at $64.85, just above the last price of $64.43 and the level a rise would meet first. The second resistance is the 52-week high of $87.03.